ERBB2 and breast cancer: The smartphone-based optical microscope platform (EpiView-D4) directly quantified protein biomarkers in cell lysates using a polymer brush-based immunodiagnostic chip (D4) and simultaneously evaluated cell morphology and HER2 protein expression in fine needle aspiration (FNA) samples for BC diagnosis [736].